Can Partnering To Fight Hepatitis C Pay At Enanta?
Enanta's partnership with the big pharma goes back to 2006, when AbbVie joined the race to develop a new treatment for the hepatitis C virus (HCV) that improved upon the traditional regimen of interferon, an injectable drug that causes unpleasant side ...
Nasdaq - Mon, 24 Nov 2014 14:41

Can Partnering To Fight Hepatitis C Pay Off For Enanta Pharmaceuticals? ENTA ...
Investor's Business Daily - Mon, 24 Nov 2014 14:07

AbbVies HCV Cocktail Treatment Closer to EU Approval - Mon, 24 Nov 2014 14:52

Enanta Pharmaceutical's (ENTA) CEO Jay Luly on Q4 2014 Results - Earnings ...
Seeking Alpha - Mon, 24 Nov 2014 15:03

Enanta Pharmaceuticals Reports Financial Results for its Fiscal Fourth Quarter ... - Mon, 24 Nov 2014 04:38

New Drug Can Cure Hepatitis C – If Only We Could Afford It
Just 5 years ago the cure rate for most patients in the US was about 50%. Now with Sovaldi, made by Gilead Sciences Inc. of California and approved by the FDA last December, the latest Hep C regimen is making therapy shorter, more tolerable, and the ...
West Virginia Public Broadcasting - Mon, 24 Nov 2014 13:00

State advisory board recommends Hep-C drug for late-stage patients only
Albany. A state advisory board voted Thursday to recommend Medicaid cover a pricey new drug for chronic hepatitis C virus, but only for people already covered by another expensive medication to treat the contagious liver disease. The Drug Utilization ...
Albany Times Union - Thu, 20 Nov 2014 22:47

France pegs Gilead hepatitis C drug at "lowest price in Europe"
Reuters - Thu, 20 Nov 2014 05:18

At The Crossroads, Part 4: New Hep C Drugs Promise A Cure, For A Big Price
Rhode Island Public Radio - Thu, 20 Nov 2014 03:15

France strikes big hep C treatment deal for Gilead's Sovaldi
FiercePharma - Thu, 20 Nov 2014 08:25

EU approval for Gilead's hep C combo Harvoni
PMLiVE - Thu, 20 Nov 2014 02:40

Hep C Drugs Cost FL Medicaid $30M So Far
WUSF News - Wed, 19 Nov 2014 08:05

Europe gives green light to AbbVie hepatitis C drugs, others
LONDON (Reuters) - European regulators recommended approval for two drugs made by AbbVie to treat hepatitis C, both of which belong to a new generation of medicines that have proved effective in treating a condition that is the most common cause of ...
Reuters - Fri, 21 Nov 2014 04:25

EMA Panel Backs Exviera, Viekirax for Chronic Hepatitis C
Medscape - Fri, 21 Nov 2014 13:11

AbbVie (ABBV) Hepatitis C Drugs Win The Nod Of European Regulators
Bidness ETC - Sat, 22 Nov 2014 04:56

AbbVie gets an EU green light for its next-gen hep C treatment
FierceBiotech - Fri, 21 Nov 2014 05:19

Costly Hep C Drugs Help Drive Spending Jump
Several factors are driving the spending spike, including the introduction of expensive new hepatitis C drugs and fewer drug patent expirations than in previous years, the report found. Such expirations typically lead to savings as cheaper generics ...
WebMD - Wed, 19 Nov 2014 22:45

Drug spending tops $1 trillion on hepatitis C, cancer therapies: study
Reuters - Wed, 19 Nov 2014 20:52

So long, patent cliff. Hello, hep C and cancer. Welcome to $1.3T in global ...
FiercePharma - Thu, 20 Nov 2014 07:14

The dirty motivation behind Gilead's hepatitis C agreement
Up to 150 million people worldwide suffer from chronic hepatitis C, which attacks the liver and, if left untreated, can lead to cirrhosis and cancer. Complications related to hepatitis C claim 500,000 lives annually. A major hurdle to treating the ...
Al Jazeera America - Thu, 20 Nov 2014 23:03

Gilead receives EU approval for hepatitis C drug Harvoni
Zenopa - Fri, 21 Nov 2014 04:58

EMA recommends two AbbVie treatments for hepatitis C
The addition of AbbVie's two treatments will provide a further option for patients with hepatitis C, which remains a European health challenge, affecting between 0.4% and 3.5% of the population in different EU member states. It is the most common ...
PMLiVE - Mon, 24 Nov 2014 04:08

Hep C wars heat up as AbbVie scores likely EU approval for Harvoni challenger
BioPharma Dive - Mon, 24 Nov 2014 07:00

Hepatitis C testing urged for baby boomers
Confirmed hepatitis C infections are up this year in Livingston County, and health officials believe many more people may be infected without realizing it. They say that baby boomers, those born between 1945 and 1965, may be most at risk and in need of ...
Livingston Daily - Mon, 17 Nov 2014 20:06

1  2  3  4  5  6  7  8    ->

We do not evaluate or guarantee the accuracy of any content in this site. Click here for the full disclaimer.

Last update: September 2014